To assess if the ICAM-1 up-modulation in cytokine-treated BC cell lines could affect the conjugate formation with NK cells, we performed neutralizing assay by using both anti-ICAM-1 and anti-LFA-1 (Fig. 3C, D). This evidence concerns the gene ICAM1 and breast cancer.